Donor NK cell infusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor NK cell infusion, covering 2024-10-15 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation. [Phase 1]